home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Gene Implicated In Rett Syndrome

  January, 11 2005 9:12
your information resource in human molecular genetics
A new gene has been identified that may be involved in the pathogenesis of Rett syndrome -- a neurological disorder resulting in autism, seizures and loss of speech, almost exclusively in girls before the age of 18 months -- as reported in the January issue of Nature Genetics.

The primary genetic cause of Rett syndrome is a mutation in the gene MECP2, encoding a protein thought generally to affect the expression of many other genes, several of which probably contribute to the disease. The search for MECP2 'target' genes that are relevant to the development of Rett syndrome has been difficult, but Terumi Kohwi-Shigematsu and colleagues have now identified the gene DLX5 as a strong candidate. The authors found that DLX5 expression was altered in the brains of mice lacking MECP2. In humans, DLX5 is an 'imprinted' gene, and is expressed only from the copy received from one's mother. In cells from individuals with Rett syndrome, however, they found that the gene was expressed from both copies, resulting in an overproduction of the protein.

DLX5 regulates the production of enzymes that synthesize gamma-aminobutyric acid (GABA), a neurotransmitter that has been linked to the development of other neurological disorders, suggesting that this pathway may have role in at least some of the features of Rett syndrome.

Author contact:
Terumi Kohwi-Shigematsu (Lawrence Berkeley Laboratory, Berkeley, CA, USA)
Tel: +1 510 486 4983
E-mail: terumiks@lbl.gov

Also available online.

(C) Nature Genetics.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.